REFERENCES
- Berry , S. M. , Berry , D. A. ( 2004 ). Accounting for multiplicities in assessing drug safety: a three-level hierarchical mixture model . Biometrics 60 ( 2 ): 418 – 426 .
- Cook , R. J. , Lawless , J. F. ( 1997 ). Marginal analysis of recurrent events and a terminating event . Stat. Med. 16 : 911 – 924 .
- Christian , M. S. ( 2001 ). Introduction/overview: Gender-based differences in pharmacologic and toxicologic responses . Int. J. Toxicol. 20 : 145 – 148 .
- Chuang-Stein , C. (1998). Safety analysis in controlled clinical trials. Drug Information J. 32:1363S–1372S.
- General Accounting Office (GAO) . ( 2001 ). Drug Safety: Most Drugs Withdrawn in Recent Years Had Greater Health Risks for Women. Draft Report 01-286 . Washington , DC : GAO .
- Liu , G. F. , Wang , J. , Liu , K. , Snavely , D. ( 2006 ). Confidence intervals for an exposure adjusted incidence rate difference with applications to clinical trials . Stat. Med. 25 ( 8 ): 1275 – 1286 .
- Nelson , W. B. ( 2003 ). Recurrent Events Data Analysis for Product Repairs, Disease Recurrences, and Other Applications . American Statistical Association and the Society for Industrial and Applied Mathematics .
- O'Neill , R. T. ( 1987 ). Statistical analyses of adverse event data from clinical trials, special emphasis on serious events . Drug Information J. 21 : 9 – 20 .
- O'Neill , R. T. ( 1995 ). Statistical concepts in the planning and evaluation of drug safety from clinical trials in drug development: Issues on international harmonisation . Stat. Med. 14 : 1117 – 1127 .
- Rosenkranz , G. ( 2006 ). Analysis of adverse events in the presence of discontinuations . Drug Information J. 40 ( 01 ): 79 – 87 .
- Wang , M. C. , Qin , J. , Chiang , C. T. ( 2001 ). Analyzing recurrent events data with informative censoring . J. Am. Stat. Assoc. 96 : 1057 – 1065 .